Publications by authors named "Marshall Cates"

Claim this Profile
P
Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis.
Suzanne C Harris, Jolene R Bostwick, Marshall E Cates, Lisa Whittington Goldstone, Amy B Werremeyer

Am J Health Syst Pharm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paliperidone-Associated Sialorrhea: A Case Report With Review of Current Literature.
Bradley G Burk, Victoria Donaldson, Cherry W Jackson, Marshall E Cates, Badari Birur

J Clin Psychopharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambitious AAPP vision necessitates bold actions.
Marshall E Cates, Cherry W Jackson

Ment Health Clin· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Istradefylline: A novel agent in the treatment of "off" episodes associated with levodopa/carbidopa use in Parkinson disease.
Lauren Cummins, Marshall E Cates

Ment Health Clin· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the Conflict Between Promoting Wellness, Perpetuating Mental Illness Stigma and Making Psychiatric Pharmacy Education Less Intense.
Suzanne C Harris, Jolene R Bostwick, Amy B Werremeyer, Lisa W Goldstone, Marshall E Cates

Am J Pharm Educ· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An internet-based survey in Japan concerning social distance and stigmatization toward the mentally ill among doctors, nurses, pharmacists, and the general public.
Tomoo Fujii, Manako Hanya, Masanori Kishi, Yuki Kondo, Marshall E Cates

Asian J Psychiatr· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curriculum in Psychiatry and Neurology for Pharmacy Programs.
Julie A Dopheide, Jolene R Bostwick, Lisa W Goldstone, Kelan Thomas, Ruth Nemire, Marshall Cates

Am J Pharm Educ· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-cycloserine in the treatment of posttraumatic stress disorder.
Joni F Baker, Marshall E Cates, David R Luthin

Ment Health Clin· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep quality among pharmacy students.
Marshall E Cates, Andraya Clark, Thomas W Woolley, Amy Saunders

Am J Pharm Educ· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with a drug screening program at a school of pharmacy.
Marshall E Cates, Michael D Hogue

J Am Coll Health· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitudes of matriculating first-year pharmacy students toward a mandatory, random drug-screening program.
Maggee Oliver, Marshall E Cates, Michael D Hogue, Susan P Alverson, Thomas W Woolley

Am J Pharm Educ· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacoeconomic evaluation of switch to olanzapine in veterans with schizophrenia or schizoaffective disorder.
Lori L Davis, Marshall E Cates, Joette S Lowe, L Charles Ward, Jeffrey D Johnson

Psychopharmacol Bull· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregabalin for the treatment of generalized anxiety disorder.
Terri M Wensel, Krystal W Powe, Marshall E Cates

Ann Pharmacother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD).
Rachel E Fargason, Karen Gamble, Kristin T Avis, Rachel C Besing, Cherry W Jackson, Marshall E Cates

Psychopharmacol Bull· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapy of eating disorders.
Cherry Wyant Jackson, Marshall Cates, Raymond Lorenz

Nutr Clin Pract· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peer evaluations can be problematic.
Marshall E Cates, Mary R Monk-Tutor

Am J Pharm Educ· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients.
Marshall E Cates, Cherry W Jackson, Jacqueline M Feldman, Amanda E Stimmel, Thomas W Woolley

Community Ment Health J· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.
Marshall E Cates, Jacqueline M Feldman, Angela A Boggs, Thomas W Woolley, Nanci P Whaley

Ann Pharmacother· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prazosin for treatment of nightmares related to posttraumatic stress disorder.
Heather R Taylor, Maisha Kelly Freeman, Marshall E Cates

Am J Health Syst Pharm· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faculty attitudes and scholarly productivity resulting from a seminar course.
Jon Bradley Nelson, Marshall E Cates, Thomas W Woolley

Am J Pharm Educ· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
Jenny Y Lam, Maisha Kelly Freeman, Marshall E Cates

Ann Pharmacother· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis